Rafferty Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.21M Sell
128,793
-51,299
-28% -$481K ﹤0.01% 726
2025
Q1
$1.28M Sell
180,092
-75,112
-29% -$534K 0.01% 686
2024
Q4
$2.98M Sell
255,204
-344
-0.1% -$4.01K 0.01% 528
2024
Q3
$5.25M Buy
255,548
+30,336
+13% +$623K 0.02% 412
2024
Q2
$5.04M Sell
225,212
-98,349
-30% -$2.2M 0.02% 413
2024
Q1
$8.9M Sell
323,561
-5,437
-2% -$150K 0.03% 307
2023
Q4
$10M Buy
328,998
+77,873
+31% +$2.37M 0.04% 278
2023
Q3
$7.94M Buy
251,125
+42,757
+21% +$1.35M 0.05% 287
2023
Q2
$8.5M Sell
208,368
-3,020
-1% -$123K 0.05% 246
2023
Q1
$7.88M Sell
211,388
-23,076
-10% -$860K 0.05% 249
2022
Q4
$8.18M Buy
234,464
+104,805
+81% +$3.66M 0.07% 253
2022
Q3
$7.26M Buy
129,659
+13,740
+12% +$769K 0.08% 207
2022
Q2
$6M Buy
115,919
+26,198
+29% +$1.36M 0.06% 253
2022
Q1
$6.52M Buy
89,721
+41,867
+87% +$3.04M 0.04% 301
2021
Q4
$5.66M Buy
47,854
+28,463
+147% +$3.37M 0.03% 338
2021
Q3
$2.6M Sell
19,391
-11,191
-37% -$1.5M 0.02% 552
2021
Q2
$4.95M Sell
30,582
-20,273
-40% -$3.28M 0.03% 322
2021
Q1
$4.08M Buy
50,855
+33,351
+191% +$2.68M 0.03% 334
2020
Q4
$952K Sell
17,504
-64,161
-79% -$3.49M 0.01% 513
2020
Q3
$1.62M Buy
81,665
+57,319
+235% +$1.14M 0.02% 474
2020
Q2
$512K Buy
+24,346
New +$512K 0.01% 707
2020
Q1
Sell
-45,492
Closed -$667K 742
2019
Q4
$667K Sell
45,492
-58,958
-56% -$864K 0.01% 639
2019
Q3
$1.39M Buy
104,450
+11,860
+13% +$158K 0.02% 469
2019
Q2
$1.52M Buy
92,590
+12,871
+16% +$211K 0.03% 483
2019
Q1
$1.36M Buy
+79,719
New +$1.36M 0.02% 493